114 related articles for article (PubMed ID: 32027262)
21. [Expression of phosphatidylinositol-3 kinase in epithelial ovarian carcinoma].
Zhang PN; Sun H
Zhonghua Fu Chan Ke Za Zhi; 2007 Mar; 42(3):196-200. PubMed ID: 17537308
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of extracellular signal-regulated kinase activity by sorafenib increases sensitivity to DNR in K562 cells.
Xiao RZ; He CM; Xiong MJ; Ruan XX; Wang LL; Chen Y; Lin DJ
Oncol Rep; 2013 May; 29(5):1895-901. PubMed ID: 23467984
[TBL] [Abstract][Full Text] [Related]
23. [Effects of bortezomib combined with daunorubicin on proliferation and apoptosis in primary adult acute leukemia].
Zhou RQ; Gong YP; Zheng BH; Yang X
Sichuan Da Xue Xue Bao Yi Xue Ban; 2010 Sep; 41(5):789-92. PubMed ID: 21302442
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of the PI3K-Akt signaling pathway enhances the sensitivity of Fas-mediated apoptosis in human gastric carcinoma cell line, MKN-45.
Osaki M; Kase S; Adachi K; Takeda A; Hashimoto K; Ito H
J Cancer Res Clin Oncol; 2004 Jan; 130(1):8-14. PubMed ID: 14605879
[TBL] [Abstract][Full Text] [Related]
25. [Effects of PD98059 and LY294002 on subcutaneous xenograft of human endometrial carcinoma in nude mice].
Guo RX; Zhang RF; Wang XY; Shi HR; Qiao YH
Zhonghua Fu Chan Ke Za Zhi; 2011 Jun; 46(6):446-52. PubMed ID: 21781587
[TBL] [Abstract][Full Text] [Related]
26. [Regulatory Effect of MiR-543 on Proliferation and Apoptosis of Human Leukemia Cell Line K562 and Its Mechanism].
Sun L; Lu J; Li TT; Men LJ; Li CC
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Jun; 27(3):763-768. PubMed ID: 31204929
[TBL] [Abstract][Full Text] [Related]
27. [Effect of Tongxinluo on Apoptosis of Rat Cardiac Microvascular Endothelial Cells].
Wei G; Li HR; Liu HL; Yao B; Chen M; Liang JQ; Jia ZH; Wu YL
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2016 Jun; 36(6):709-17. PubMed ID: 27491231
[TBL] [Abstract][Full Text] [Related]
28. Effect of nitric oxide on the daunorubicin efflux mechanism in K562 cells.
Curta JC; de Moraes AC; Licínio MA; Costa A; Santos-Silva MC
Cell Biol Int; 2012 Jun; 36(6):529-35. PubMed ID: 22360312
[TBL] [Abstract][Full Text] [Related]
29. [Cyr61 expression influences cancer cell proliferation and apoptosis via PI3K pathway in human ovarian carcinoma cells].
Xiao L; He C; Li X; Chen Y; Zhou JD
Zhonghua Fu Chan Ke Za Zhi; 2012 Aug; 47(8):616-20. PubMed ID: 23141184
[TBL] [Abstract][Full Text] [Related]
30. [Effect of MiRNA-145 on Apoptosis of Leukemia HuT 78 Cells and Its Mechanism].
Li ZH; Zhang YP; Xing PT; Zhan XR
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Feb; 28(1):104-109. PubMed ID: 32027261
[TBL] [Abstract][Full Text] [Related]
31. [Antiproliferative effects of LY294002 on MCL Jeko-1 cell line and its mechanism].
Chen HP; Huang YQ; Ma XD
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Oct; 21(5):1183-6. PubMed ID: 24156430
[TBL] [Abstract][Full Text] [Related]
32. [Effect and mechanism of LY294002 on growth of fibrosarcoma cell line HT1080].
Zhou H; Huang XY; Yang T; Wang T; Xu D; Wen FQ
Sichuan Da Xue Xue Bao Yi Xue Ban; 2010 Jan; 41(1):20-3. PubMed ID: 20369463
[TBL] [Abstract][Full Text] [Related]
33. Pharmacological p38 MAPK inhibitor SB203580 enhances AML stem cell line KG1a chemosensitivity to daunorubicin by promoting late apoptosis, cell growth arrest in S-phase, and miR-328-3p upregulation.
Bahattab S; Assiri A; Alhaidan Y; Trivilegio T; AlRoshody R; Huwaizi S; Almuzzaini B; Alamro A; Abudawood M; Alehaideb Z; Matou-Nasri S
Saudi Pharm J; 2024 Jun; 32(6):102055. PubMed ID: 38699598
[TBL] [Abstract][Full Text] [Related]
34. Molecular mechanisms of converting K562/DNR cellular drug-resistance by bortezomib.
Li YC; Wang HH; Liao AJ; Fu BB; Zhang R; Li J; Yang Y; Liu ZG; Yang W
Eur Rev Med Pharmacol Sci; 2014; 18(10):1465-72. PubMed ID: 24899604
[TBL] [Abstract][Full Text] [Related]
35. Proteasome inhibitor bortezomib overcomes P-gp-mediated multidrug resistance in resistant leukemic cell lines.
Zheng B; Zhou R; Gong Y; Yang X; Shan Q
Int J Lab Hematol; 2012 Jun; 34(3):237-47. PubMed ID: 22145750
[TBL] [Abstract][Full Text] [Related]
36. [Effect of bortezomib on MAPK signaling pathway of K562/DNR cells].
Liao AJ; Fu BB; Wang HH; Li YC; Yao K; Zhang R; Yang W; Liu ZG
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Dec; 18(6):1460-3. PubMed ID: 21176351
[TBL] [Abstract][Full Text] [Related]
37. Phosphatidylinositol 3-kinase inhibitor LY294002 suppresses proliferation and sensitizes doxorubicin chemotherapy in bladder cancer cells.
Wu D; Tao J; Xu B; Qing W; Li P; Lu Q; Zhang W
Urol Int; 2011; 87(1):105-13. PubMed ID: 21597260
[TBL] [Abstract][Full Text] [Related]
38. [Inhibitory Effect of LY294002 on Proliferation of Multiple Myeloma Cells and Its Mechanism].
Wang YQ; Lin Y; Zhao JD; Yang YT
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Aug; 25(4):1092-1096. PubMed ID: 28823274
[TBL] [Abstract][Full Text] [Related]
39. [The relationship between cytochrome P450, subfamily IIIA, polypeptide 5 gene and drug resistance in leukemia cell lines].
Wang T; Chen FY; Han JY; Zhong JH; Teng Y; Ouyang RR
Zhonghua Nei Ke Za Zhi; 2004 Jul; 43(7):527-9. PubMed ID: 15312409
[TBL] [Abstract][Full Text] [Related]
40. [Effects of specific siRNA targeting at bcr-abl fusion gene and its combination with p27 gene clone on chronic myeloid leukemia cell line K562].
Wang W; DU Y; Lin GQ; Li NN; Sun BZ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Jun; 18(3):606-11. PubMed ID: 20561411
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
